OCUL
Ocular Therapeutix Inc
10.50$
+5.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +41.1% | -32.1% | -26.0% | +31.8% | +7.8% | +232.6% | -21.8% | -27.1% | +68.8% | +81.7% | +76.5% | |
| – | +40.4% | -34.7% | -38.0% | +29.7% | +7.1% | +309.1% | -22.3% | -32.2% | +79.2% | +89.9% | +77.4% | |
| – | -17.7% | +7.0% | +26.1% | +30.2% | +0.7% | +318.9% | -28.0% | -37.7% | +91.4% | +100.2% | +88.0% | |
| – | +40.4% | -35.1% | -39.0% | +30.2% | +0.7% | +318.9% | -28.0% | -37.7% | +91.4% | +100.2% | +88.0% | |
| – | -41.3% | +29.5% | -9.6% | -11.1% | +1,167.7% | +380.8% | +72.5% | +0.9% | +22.8% | +23.7% | -5.4% | |
| – | +0.8% | -15.7% | +8.0% | +77.9% | +339.6% | +25.9% | +4.1% | +57.9% | +16.8% | +31.9% | +17.2% | |
| – | +73.7% | +7.0% | +216.3% | -2.3% | -0.8% | -20.3% | +46.1% | -16.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.3% | +10.7% | +27.7% | +26.9% | +121.6% | +125.5% | -37.1% | -2.5% | +41.3% | -11.4% | +7.8% | |
| – | -8.4% | +54.3% | +61.8% | -31.8% | +31.3% | +121.7% | -1.2% | +19.2% | +11.2% | +18.5% | +22.9% | |
| – | +1,027.9% | -89.9% | +258.0% | – | – | +756.8% | -83.2% | -1.5% | -0.8% | +21.9% | +45.7% | |
| – | +48.7% | +8.1% | +68.8% | -17.0% | +10.2% | -17.1% | +69.5% | +11.6% | -14.3% | -4.9% | -0.5% | |
| – | +13.0% | -7.7% | -11.5% | +98.8% | +98.9% | -16.4% | +24.7% | +5.0% | +38.7% | -8.6% | +4.1% | |
| – | +52.6% | -41.9% | -49.7% | +37.2% | -110.1% | – | +15.6% | -59.8% | +157.6% | +246.0% | +107.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +118.2% | +6.8% | +16.1% | +32.3% | +18.8% | +34.2% | +35.2% | +0.6% | +3.6% | +84.9% | +18.3% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.